Acumen Pharmaceuticals (ABOS) Earnings Date & Reports

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ABOS is expected to report earnings to fall 15.33% to -38 cents per share on November 16

Acumen Pharmaceuticals ABOS Stock Earnings Reports

Q3'26

Est.

$-0.38

Q2'26

Missed

by $0.09

Q1'26

Beat

by $0.04

Q4'25

Beat

by $0.06

Q3'25

Beat

by $0.16

The last earnings report on August 12 showed earnings per share of -44 cents, missing the estimate of -36 cents. With 165.99K shares outstanding, the current market capitalization sits at 166.33M.

View a ticker or compare two or three

ABOS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ABOS